- Trials with a EudraCT protocol (27)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
27 result(s) found for: Chronic Pancreatitis AND Pain.
Displaying page 1 of 2.
EudraCT Number: 2008-002671-27 | Sponsor Protocol Number: 28.04.2008 | Start Date*: 2008-07-14 | |||||||||||
Sponsor Name:Department of Medical Gastroenterology | |||||||||||||
Full Title: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP CLINICAL AND EXPERIMENTAL PILOTSTUDY OF PREGABALIN IN PATIENTS WITH CHRONIC PANCREATITIS | |||||||||||||
Medical condition: Chronic pancreatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000647-24 | Sponsor Protocol Number: HEEL-2011-01 | Start Date*: 2011-07-26 | ||||||||||||||||
Sponsor Name:Radboud University Nijmegen Medical Centre | ||||||||||||||||||
Full Title: The safety, tolerability, and analgesic efficacy of Δ9-THC (Namisol®) in chronic pancreatitis patients suffering from persistent abdominal pain | ||||||||||||||||||
Medical condition: patients with abdominal pain as a result of chronic pancreatitis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male | |||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-002445-31 | Sponsor Protocol Number: SIMBA-16 | Start Date*: 2017-01-20 | ||||||||||||||||
Sponsor Name:Enrique de Madaria | ||||||||||||||||||
Full Title: SIMBA trial: Simvastatin in the Prevention of Recurrent Acute Pancreatitis, a Triple Blind Randomized Controlled Trial | ||||||||||||||||||
Medical condition: Recurrent acute pancreatitis (RAP) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000730-19 | Sponsor Protocol Number: HEEL-2011-02 | Start Date*: 2012-08-23 | |||||||||||
Sponsor Name:Radboud University Nijmegen Medical Centre | |||||||||||||
Full Title: The analgesic efficacy of Δ9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain: a Randomized, Double-blinded, Placebo-controlled, Parallel Design | |||||||||||||
Medical condition: Chronic pancreatitis with persistant abdominal pain | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000375-42 | Sponsor Protocol Number: S339.2.001 | Start Date*: 2008-02-21 | |||||||||||
Sponsor Name:Solvay Pharmaceuticals GmbH | |||||||||||||
Full Title: A multi-center, double-blind, parallel-design, randomized, placebo-controlled, dose-ranging study to assess the efficacy and safety of oral recombinant microbial lipase (SLV339) in subjects with pa... | |||||||||||||
Medical condition: Pancreatic exocrine insufficiency due to chronic pancreatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) SE (Prematurely Ended) HU (Prematurely Ended) CZ (Completed) LV (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003357-17 | Sponsor Protocol Number: Ketamin_SST01 | Start Date*: 2013-11-01 | ||||||||||||||||
Sponsor Name:Prof. Asbjørn Mohr Drewes | ||||||||||||||||||
Full Title: RESET Trial A randomized, double-blinded, single-centre, parallel-group, placebo-controlled, prospective trial of S-ketamine for pain treatment in chronic pancreatitis (RESET trial) | ||||||||||||||||||
Medical condition: Chronic Pancreatitis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-004004-12 | Sponsor Protocol Number: S245.3.124 | Start Date*: 2008-02-28 | ||||||||||||||||
Sponsor Name:Solvay Pharmaceuticals GmbH | ||||||||||||||||||
Full Title: A STUDY TO INVESTIGATE THE EFFECT OF PANCRELIPASE DELAYED RELEASE CAPSULES ON MALDIGESTION IN PATIENTS WITH EXOCRINE PANCREATIC INSUFFICIENCY DUE TO CHRONIC PANCREATITIS AND PANCREATECTOMY | ||||||||||||||||||
Medical condition: Pancreatic enzyme replacement therapy is the cornerstone of nutritional management of pancreatic exocrine insufficiency (PEI) due to e.g. cystic fibrosis, chronic pancreatitis, partial or complete ... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: BG (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-000087-83 | Sponsor Protocol Number: 2929 | Start Date*: 2008-12-19 | ||||||||||||||||
Sponsor Name:University of Liverpool
[...]
1. University of Liverpool
2. The Royal Liverpool and Broadgreen University Hospitals NHS Trust |
||||||||||||||||||
Full Title: EUROPAC2 trial to investigate the efficacy of ANTOX(vers) 1.2 and MGCT (magnesiocard) for the treatment of hereditary pancreatitis and idiopathic chronic pancreatitis. | ||||||||||||||||||
Medical condition: Hereditary Pancreatitis and Idiopathic Chronic Pancreatitis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003652-20 | Sponsor Protocol Number: Ptcl-01501 | Start Date*: 2013-12-04 | |||||||||||
Sponsor Name:D-Pharm Ltd. | |||||||||||||
Full Title: Pilot trial of intravenous DP-b99 in the treatment of first-ever episode of non-obstructive acute high-risk pancreatitis | |||||||||||||
Medical condition: Acute pancreatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) SK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006958-10 | Sponsor Protocol Number: 01/06/57 | Start Date*: 2007-09-26 |
Sponsor Name:Pharmanord, UK, LTD | ||
Full Title: Anticipate Trial - Randomized, Double blind, placebo-controlled, multicentre Trial of Anti-oxidant therapy in painful chronic pancreatitis. | ||
Medical condition: Chronic Pancreatitis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-000562-38 | Sponsor Protocol Number: BCBe/03/Pan-CPI/002 | Start Date*: 2010-04-20 | |||||||||||
Sponsor Name:Berlin-Chemie AG | |||||||||||||
Full Title: RANDOMISED, DOUBLE BLIND, PLACEBO CONTROLLED PHASE IV TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A GASTRO-RESISTANT FILM-COATED PANCREATIN TABLET FOR LIPID DIGESTION AND ABSORPTION IN PATIENTS WI... | |||||||||||||
Medical condition: The purpose of this trial is to evaluate the clinical efficacy and safety of a gastro-resistant film-coated tablet in comparison to placebo in the treatment of pancreatic exocrine insufficiency due... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-020303-69 | Sponsor Protocol Number: 2010Axcan9682 | Start Date*: 2011-09-19 | |||||||||||
Sponsor Name:Erasmus MC | |||||||||||||
Full Title: Enzyme substitution in exocrine pancreatic insufficiency; Self administration against a fixed dose regimen. | |||||||||||||
Medical condition: Exocrine pancreatic insufficiency in patients with chronic pancreatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000736-24 | Sponsor Protocol Number: BCBe/03/Pan-CPI/003 | Start Date*: 2005-07-14 | |||||||||||
Sponsor Name:Berlin-Chemie AG | |||||||||||||
Full Title: RANDOMISED, DOUBLE BLIND, PLACEBO CONTROLLED PHASE IV TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF AN ENTERIC-COATED PANCREATIN TABLET FOR LIPID DIGESTION AND ABSORPTION IN PATIENTS WITH PANCREATIC... | |||||||||||||
Medical condition: The purpose of this trial is to evaluate the clinical efficacy and safety of an enteric-coated pancreatin tablet in comparison to placebo in the treatment of pancreatic exocrine insufficiency due t... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000732-34 | Sponsor Protocol Number: ABOXY_2017 | Start Date*: 2017-06-21 | ||||||||||||||||||||||||||
Sponsor Name:Mech-Sense, Dept. Gastroenterology & Hepatology, Aalborg University Hospital | ||||||||||||||||||||||||||||
Full Title: Oral Controlled Release Formulations to Patients with Gastrointestinal Dysfunction – Is the Release of Drug and the Absorption Impaired? | ||||||||||||||||||||||||||||
Medical condition: Healthy (pain) and patients (pain). | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-002468-89 | Sponsor Protocol Number: PANZ25STEA04-01 | Start Date*: 2004-10-28 | |||||||||||
Sponsor Name:Axcan Pharma S.A. | |||||||||||||
Full Title: A RANDOMISED, DOUBLE-BLIND, PLACEBO CONTROLLED PHASE IV TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PANCREATIN VS. PLACEBO FOR LIPID DIGESTION AND ABSORPTION IN PATIENTS WITH PANCREATIC EXOCRINE I... | |||||||||||||
Medical condition: The purpose of this clinical trial is to evaluate the clinical efficacy and safety of a capsule containing enteric-coated porcine pancreatin microfilm tablets in comparison with placebo in the trea... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-005187-24 | Sponsor Protocol Number: OROS-ANA-3001 | Start Date*: 2005-08-16 | |||||||||||
Sponsor Name:JANSSEN-CILAG | |||||||||||||
Full Title: Randomized, open label, comparative parallel group study to assess efficacy and safety of flexible dosages of OROS hydromorphone once-daily compared to sustained release oxycodone twice-daily in su... | |||||||||||||
Medical condition: Treatment of chronic non-malignant pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) DE (Completed) CZ (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-001540-60 | Sponsor Protocol Number: MULTIPAIN6-2013 | Start Date*: 2013-08-08 | |||||||||||
Sponsor Name:Mech-Sense, Aalborg University Hospital | |||||||||||||
Full Title: A novel approach to assess gastrointestinal adverse effects of opioids | |||||||||||||
Medical condition: Opioid-induced bowel dysfunction. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-002782-32 | Sponsor Protocol Number: C13006 | Start Date*: 2009-03-02 | |||||||||||
Sponsor Name:Millennium Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction and Maintenance of Clinical Response and Remission by MLN0002 in Patients with Moderate to Severe Ulcerative C... | |||||||||||||
Medical condition: Moderate to Severe Ulcerative Colitis Colitis ulcerosa moderada o grave | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) EE (Completed) HU (Completed) AT (Completed) IE (Completed) LV (Completed) CZ (Completed) NL (Completed) DK (Completed) IS (Completed) PT (Prematurely Ended) BE (Completed) FR (Completed) GB (Completed) BG (Completed) IT (Completed) MT (Completed) DE (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-001913-34 | Sponsor Protocol Number: TP-434-008 | Start Date*: 2013-08-16 | |||||||||||
Sponsor Name:Tetraphase Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy and Safety of Eravacycline Compared with Ertapenem in Complicated Intra-abdominal Infections | |||||||||||||
Medical condition: Complicated Intra-abdominal Infections | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Completed) CZ (Completed) EE (Completed) LT (Completed) DE (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002208-21 | Sponsor Protocol Number: TP-434-025 | Start Date*: 2016-09-27 | |||||||||||
Sponsor Name:Tetraphase Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy and Safety of Eravacycline Compared with Meropenem in Complicated Intra-abdominal Infections | |||||||||||||
Medical condition: Complicated Intra-abdominal Infections | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) CZ (Completed) LV (Completed) EE (Completed) LT (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
